Home Tags Commercial Agreement

Tag: Commercial Agreement

MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip

MIMETAS and Hubrecht Organoid Technologies (HUB) have entered into a strategic collaboration to market organoid models on a Chip. The agreement includes a license to MIMETAS to market HUB Organoids in an assay ready format, as well as a collaborative effort to...

Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain

Grünenthal, a global leader in pain management, and Mesoblast Limited, a world leader in allogeneic cellular medicines for inflammatory diseases, have entered into a strategic partnership to develop and commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the treatment of chronic...

Evotec And Indivumed Form Agreement Granting Access To CRC Cohort Of IndivuType Database

Evotec SE and Indivumed GmbH have announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer ("CRC"). The collaboration, which runs for an initial term of two years, will combine Evotec's proprietary...

ThermoGenesis Expands Commercial Access To Its Bioprocessing Equipment

ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics, and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, has announced that its AXP® II System for cord blood processing and PXP® System for point-of-care harvesting of highly...

Trans-Hit Bio And Maricopa Integrated Health System Biobank Work Together To Support Industry R&D

Trans-Hit Bio (THB) is the worldwide biospecimen access CRO, founded in 2009, headquartered in Montréal, Québec, with a most extensive collection capability for biospecimens and clinical samples through an unrivalled worldwide partnered-network of state-of-the-art biorepositories. The company, led by...

⭐ Recently Featured

🔥 Popular Posts

X